Capital Federal, Argentina

Victoria Wargon

This inventor holds 1 USPTO granted patent. Top assignee: Fundacion Sales. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria Wargon. Retrieved from https://idiyas.com/inventor/victoria-wargon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Victoria Wargon: Innovator in Cancer Treatment

Introduction

Victoria Wargon is a prominent inventor based in Capital Federal, Argentina. She has made significant contributions to the field of cancer treatment, particularly focusing on methods to address antiprogestin-resistant cancers. Her innovative work aims to improve the lives of cancer patients, especially those suffering from breast cancer.

Latest Patents

Victoria Wargon holds 1 patent for her invention titled "Methods and compositions for treating antiprogestin-resistant cancers." This patent provides methods and compositions for treating cancer patients who are responsive to antiprogestin therapy or who may be induced to be responsive through the administration of a demethylation agent, optionally together with an HDAC inhibitor. Additionally, her invention includes a method of screening cancer patients using BCL-XL as a marker protein.

Career Highlights

Victoria Wargon is associated with Fundacion Sales, where she continues her research and development in cancer therapies. Her dedication to advancing medical science has positioned her as a key figure in her field.

Collaborations

Some of her notable coworkers include Claudia L Lanari and Paola Rojas, who contribute to her research efforts and collaborative projects.

Conclusion

Victoria Wargon is a trailblazer in the fight against cancer, with her innovative approaches offering hope to many patients. Her work exemplifies the impact of dedicated research in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…